The answer for skin cancer

The answer for skin cancer
Posted by Dr Keefe on October 1, 2008, 5:27 pm

BEC5 / Curaderm contains a specially purified plant extract from the Solanum Sodomaeum, the so-called Devil's apple- which is found in the Australasia region.
The answer for skin cancer

BEC5 / Curaderm contains a specially purified plant extract from the Solanum Sodomaeum, the so-called Devil's apple- which is found in the Australasia region. The extract, known as Solasodine Glycosides, (0.005%) is also found in smaller quantities in the eggplant and aubergine.

After two decades of research and clinical trials, biochemist, Dr. Bill E. Cham, has discovered that BEC5 when applied topically can eradicate non-melanoma skin cancers, specifically:

* Basal cell carcinomas (BCC).
* Squamous cell carcinomas (SCC).

BEC5 cream has also been shown to be efficacious with benign tumours, including:

* Keratoses.
* Keratoacanthomas.
* Sun spots.
* Age spots.

Numerous clinical trials in Australia and Great Britain have confirmed BEC5's ability to regress non-melanoma skin cancers. In one open study with 72 patients, treatment with BEC5 cream resulted in the regression of all treated lesions (56 actinic keratoses, 39 BCCs and 29 SCCs), with 100% healed after 1 to 13 weeks of treatment.

Recent trials in 10 UK hospitals found that a twice daily topical application of BEC5 cream to the affected areas gave a complete remission to 78% of the patients within 8-weeks. The remaining 22% of patients had also improved and needed longer treatment times, all this was made possible without chemotherapy, radiotherapy or surgery.

The dermatologists at the Royal London Hospital concluded that: "BEC5 is a topical preparation which is safe and effective, an ideal therapy for outpatient treatment... It is a cost effective treatment for both primary and secondary skin cancer care."

Furthermore, the histological analyses of biopsies taken before, during and after treatment give compelling evidence of the continuing efficacy of BEC5 because treated skin cancer lesions have not recurred for at least 5 years after cessation of therapy.